Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Biotech Regeneron replaces Intel as sponsor of Science Talent Search

Published 05/26/2016, 08:41 AM
© Reuters. U.S. President Barack Obama is pictured with finalists of the Intel Science Talent Search in the Eisenhower Executive Office Building in Washington

By Ransdell Pierson

NEW YORK (Reuters) - Biotechnology company Regeneron Pharmaceuticals Inc (NASDAQ:REGN) on Thursday became the title sponsor of the most prestigious U.S. science competition for high school students, taking the baton from chipmaker Intel Corp (NASDAQ:INTC).

Regeneron pledged $100 million to support the Science Talent Search and related programs through 2026, and doubled awards for the top 300 scientists and their schools, to $2,000 each.

Regeneron's two top executives competed in the annual event during the 1970s and went on to build one of the world's biggest biotech companies, with cutting-edge drugs for fighting macular degeneration, cancer and cholesterol.

The fast-growing biotech company will take over as named sponsor from Intel, whose chips were helping build the personal computer industry in 1998 when it took over as sponsor from Westinghouse. That storied electronics and industrial giant had sponsored the talent search from 1942 to 1997.

The competition, overseen by the nonprofit Society for Science & the Public, receives applications annually from more than 1,800 high school seniors, along with their original research in all areas of science, including mathematics.

The field is winnowed to 300 young scientists, among whom 40 become finalists for a competition in Washington, D.C.

Regeneron Chief Executive Len Schleifer competed in the Westinghouse Science Talent Search in 1970 with a project on Euclidian geometry. Company research chief George Yancopoulos was a top winner in 1976 for research that involved cutting protozoans in half to see what factors enabled the tiny organisms to regenerate.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The young scholars stuck to the regeneration theme when Schleifer started Regeneron in 1988, with Yancopoulos its founding scientist. The company focused on discovering nerve-growth proteins that could regenerate neurons. They hoped to find cures for Parkinson's disease and Alzheimer's disease.

Those lofty efforts failed, but the company kept the Regeneron name as it changed course and focused on other diseases.

A teacher at Forest Hills High School, in Queens, New York, encouraged Schleifer to enter the Westinghouse competition and gave him inspiration that has lasted a lifetime.

"It taught me the value of having a teacher who really cared and served as my mentor," said Schleifer. He expressed concern that many fine young scientific minds have been lost over recent decades to more-glamorous fields like investment banking, but said the Regeneron Science Talent Search will hopefully keep many others on track.

Intel in March said its sponsorship would be ending but provided no details. Company executives declined further comment on Wednesday, including whether the discontinued sponsorship was related to austerity moves as Intel moves forward with 12,000 planned job cuts globally.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.